Clinical Trial Update: A Clinical Trial to Evaluate AZD7648 Alone and in Combination With Other Anti-cancer Agents in Patients With Advanced Cancers. [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating AZD7648 alone and in combination with other anti-cancer agents in patients with advanced malignancies has completed enroll…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignancies

Drugs mentioned

• AZD7648

Snippet

Sponsor: AstraZeneca | Conditions: Advanced Malignancies | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2024-02-06